CORC

在结果中检索

CORC

浏览/检索结果: 共60条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Xu, Nong;  Shen, Lin;  Dai, Guanghai
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Predictive Value of Tumor-Infiltrating Lymphocytes to Pathological Complete Response in Neoadjuvant Treated Triple-Negative Breast Cancers 会议论文
作者:  Ruan, Miao;  Tian, Tian;  Rao, Jia;  Xu, Xiaoli;  Yu, Bao-Hua
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Shi, Jianhua;  Feng, Ji Feng;  Shen, Lin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Predictive Value of Tumor-Infiltrating Lymphocytes to Pathological Complete Response in Neoadjuvant Treated Triple-Negative Breast Cancers 会议论文
作者:  Ruan, Miao;  Tian, Tian;  Rao, Jia;  Xu, Xiaoli;  Yu, Bao-Hua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. 会议论文
作者:  Li, Jin;  Xu, Ruihua;  Bai, Yuxian;  Xu, Jianming;  Liu, Tianshu
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Trastuzumab plus docetaxel and capecitabine for first-line treatment of Her2-positive advanced gastric cancer: A phase II, multi-center, open-label, singlearm study. 会议论文
作者:  Wang, Feng;  Liu, Tian Shu;  Yuan, Xianglin;  Gu, Kangsheng;  Yuan, Ying
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace